RTI-55

 

RTI-55 resources

External links

RTI-55 on Wikipedia

Brief summary - RTI-55

RTI(-4229)-55, also called RTI-55 or iometopane, is a phenyltropane-based psychostimulant used in scientific research and in some medical applications. This drug was first cited in 1991. RTI-55 is a non-selective dopamine reuptake inhibitor derived from methylecgonidine. However, more selective analogs are derived by conversion to pyrrolidinoamido RTI-229, for instance. Due to the large bulbous nature of the weakly electron withdrawing iodo halogen atom, RTI-55 is the most strongly serotonergic of the simple para-substituted troparil based analogs. In rodents RTI-55 actually caused death at a dosage of 100 mg/kg, whereas RTI-51 and RTI-31 did not. Another notable observation is the strong propensity of RTI-55 to cause locomotor activity enhancements, although in an earlier study, RTI-51.

RTI-55 - AI prompts and tools

1. As a Professor: - Act as a professor, expand and write a detailed article on RTI-55.
2. Encyclopedia Entry: - Generate a comprehensive encyclopedia article on the topic of RTI-55.
3. Subject Matter Expertise: - Expand and refine the content provided to create a professional article on RTI-55 with references.

Generative AI tools and links to learn more on RTI-55: (caution advised) ChatGPT - Bing chat - Google Bard

Note:Feel free to use AI tools to expand this topic using the text on the page followed by the prompt.

This article is a stub. Help WikiMD grow by registering to expand it. WikiMD: A comprehensive, free health & wellness encyclopedia. Note: Editing is available to registered and verified users. Click here to edit.